Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2021 07:30 ET | Source: KemPharm

KemPharm Participating in BIO @ JPM and Fierce JPM Week 2021 Virtual Events During “J.P. Morgan Week 2021”

CELEBRATION, Fla., Jan. 13, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today...
January 08, 2021 08:30 ET | Source: KemPharm

KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market

Common stock will begin trading on The Nasdaq Capital Market under the ticker symbol “KMPH” today, January 8, 2021 CELEBRATION, Fla., Jan. 08, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:...
December 23, 2020 18:11 ET | Source: KemPharm

KemPharm Announces 1-for-16 Reverse Stock Split

CELEBRATION, Fla., Dec. 23, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today...
December 22, 2020 07:30 ET | Source: KemPharm

KemPharm Files IND for KP879 for the Treatment of Stimulant Use Disorder

CELEBRATION, Fla., Dec. 22, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today...
December 02, 2020 07:30 ET | Source: KemPharm

KemPharm Participates in KP415 Late-Cycle Communication Meeting with FDA

CELEBRATION, Fla., Dec. 02, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today...
November 30, 2020 07:30 ET | Source: KemPharm

REMINDER: KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event

Online Event Scheduled for Wednesday, December 2, 2020 at 10:00 a.m., ET CELEBRATION, Fla., Nov. 30, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company...
November 23, 2020 16:30 ET | Source: KemPharm

KemPharm Provides Update on Development Pipeline

IND for KP879 Expected to be Filed Before Year-End 2020; New Prodrug Candidate Added to Pipeline, Targeting Rare CNS Disease, Idiopathic Hypersomnia (IH) CELEBRATION, Fla., Nov. 23, 2020 (GLOBE...
November 18, 2020 08:30 ET | Source: KemPharm

KemPharm and Corium to Co-Host “KP415 Market Opportunity and Commercialization Strategy” Investor Event

Online Event Scheduled for Wednesday, December 2, 2020 at 10:00 a.m., ET CELEBRATION, Fla., Nov. 18, 2020 (GLOBE NEWSWIRE) -- KemPharm, Inc. (OTCQB: KMPH), a specialty pharmaceutical company...
October 29, 2020 16:05 ET | Source: KemPharm

KemPharm Reports Third Quarter 2020 Financial Results

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Corporate and Regulatory Highlights: Announced expanded relationship with Corium...
October 26, 2020 08:30 ET | Source: KemPharm

KemPharm Postpones Special Meeting of Stockholders, Announces Date for Q3 2020 Results Call

Special Meeting of Stockholders Rescheduled to Tuesday, Nov 17, 2020, 8:00 a.m. ET Q3 2020 Results Conference Call and Live Audio Webcast Scheduled for Thursday, Oct 29, 2020, 4:30 p.m. ET ...